Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab

Interpretation of changes in the T1- and T2-weighted MR images from patients with newly diagnosed glioblastoma (GBM) treated with standard of care in conjunction with anti-angiogenic agents is complicated by pseudoprogression and pseudoresponse. The hypothesis being tested in this study was that 3D...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Neurooncol
Autori principali: Nelson, Sarah J., Li, Yan, Lupo, Janine M., Olson, Marram, Crane, Jason C., Molinaro, Annette, Roy, Ritu, Clarke, Jennifer, Butowski, Nicholas, Prados, Michael, Cha, Soonmee, Chang, Susan M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2016
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5069332/
https://ncbi.nlm.nih.gov/pubmed/27535746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-016-2229-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi